A5082483227- Glaucoma and retinal disorders
- Ocular Diseases and Behçet’s Syndrome
- Retinal Imaging and Analysis
- Cerebral Venous Sinus Thrombosis
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Diversity and Career in Medicine
- Vasculitis and related conditions
- Systemic Lupus Erythematosus Research
- Neurosurgical Procedures and Complications
- Multiple Sclerosis Research Studies
- Ophthalmology and Eye Disorders
- Health Systems, Economic Evaluations, Quality of Life
- Ophthalmology and Visual Health Research
- Sex and Gender in Healthcare
- Sarcoidosis and Beryllium Toxicity Research
- scientometrics and bibliometrics research
- Pituitary Gland Disorders and Treatments
- Empathy and Medical Education
- Intraoperative Neuromonitoring and Anesthetic Effects
- Pharmaceutical industry and healthcare
- Meningioma and schwannoma management
- Mental Health and Patient Involvement
- Auditing, Earnings Management, Governance
- Health and Medical Research Impacts
University of Toronto
2022-2025
McMaster University
2019-2024
Toronto Western Hospital
2023-2024
Kaplan (United States)
2023-2024
Mount Sinai Hospital
2024
Hamilton Health Sciences
2023
Kensington Health
2022
Chinese University of Hong Kong
2005
To investigate sex, racial, and ethnic disparities in patient enrollment across cataract trials registered the United States.
This cross-sectional study investigates the current landscape of generative artificial intelligence (GenAI) guidelines across ophthalmology journals.
Importance As critical determinants of scientific rigor, reproducibility, and equity, sex gender should be considered in clinical trial design reporting. Objective To evaluate the accuracy reporting extent sex- gender-based analysis trials associated with US Food Drug Administration (FDA) drug approvals between January 1, 1995, December 31, 2022. Design, Setting, Participants In this cross-sectional study participants enrolled FDA ophthalmology trials, following documents were reviewed by...
This study aimed to determine whether magnetic resonance imaging (MRI) biomarkers are associated with visual prognosis in myelin oligodendrocyte protein (MOG)-associated optic neuritis (ON).
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA Ophthalmology HomeNew OnlineCurrent IssueFor Authors Podcast JAMA+ AI Journals Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning / CMESubscribeJobsInstitutions LibrariansReprints Permissions Terms Use Privacy...